London
18 °C
Manchester
17 °C
Glasgow
Dublin
Belfast
Washington
21 °C
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
26 °C
Phoenix
Los Angeles
28 °C
27 °C
7 °C
12 °C
31 °C
Featured
Last news
TRNR Completes Acquisition of Ergatta, Confirms Increased 2026 Pro Forma Revenue Guidance of $30m+
Ergatta's 2026 Revenue Expected to Exceed $10 Million with Approximately 30% EBITDA MarginTRNR received $6.4 Million on March 4th from Sportstech and paid $1.8 Million to Ergatta shareholders to Close AcquisitionErgatta is Expected to Generate Cashflow for TRNR in 2026 in Excess of Closing Cash Consideration
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / March 11, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, March 12, 2026 at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com.
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, is pleased to announce that it will be presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, Florida.
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities
Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoptionEBV services offering enabled with preferred pricing being made immediately available to providers, partners and the Wellgistics Pharmacy NetworkEBV market expected to grow from $2.39 billion in 2025 to $3 billion in 2030 according to The Business Research Company1
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
Patent momentum expands Revive's bucillamine franchise across medical countermeasures, infectious diseases and additional high-value strategic applications
Police say deadly Swiss bus fire could be deliberate
A bus caught fire in western Switzerland on Tuesday killing at least six people and injuring five others in what police said may have been a deliberate act.
Family of Canada mass shooting victim sues OpenAI
The family of a girl gravely injured during a mass shooting in Canada is suing OpenAI over the company's failure to notify police about the killer's troubling activity on its ChatGPT chatbot, lawyers said Tuesday.
Gunfire at US consulate in Toronto a 'national security incident': police
Two men fired multiple shots at the US consulate in Toronto early Tuesday in what police described as a "national security incident," prompting beefed-up protection for US and Israeli diplomatic buildings in the city.
Middle East war : global economic fallout
Here are the latest economic events in the Middle East war on Tuesday:
Journalists face restrictions, detention covering Mideast war
Journalists covering the war in the Middle East are facing increasing restrictions and censorship imposed by governments and armed groups, with reporters being stopped and questioned or even detained, a survey of AFP bureau chiefs from the region showed.
Nicaragua ramping up repression of exiles: UN experts
While ramping up its repression at home, Nicaragua's government is also going after exiles abroad, with hundreds if not thousands of people affected, UN investigators said Tuesday.
Disappearances multiply in strongman Doumbouya's Guinea
More than a year after his abduction in Guinea by men in fatigues, Abdoul Sacko is still grappling with the physical and psychological scars of the torture he endured.
Travel Nevada Invites Visitors to Experience Spring and Summer Across the Silver State
Unique events and outdoor adventures showcase Nevada's rich spirit and culture
As Spring Awakens, New Children's Book 'Are You Here?' Invites Families to Notice the Signs of Love That Never Leave Us
NASHVILLE, TN / ACCESS Newswire / March 10, 2026 / As spring returns and the natural world begins to bloom again, a new children's book encourages families to pause, reflect, and notice the quiet signs of love that surround us every day. In Are You Here?, author Jenny Robinson Clark makes her children's book debut with a gentle exploration of one of life's most tender and enduring questions: Are our loved ones still with us after they pass?
Path Fertility Releases its Company Facts Sheet
SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled the Path Fertility Facts Sheet, a copy of which is embedded below within this news release.
For Couples in "Fertility Limbo," a Real-World Study Published by JARG Finds "Normal" Semen Analysis May Not Tell the Whole Story
A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic sperm-quality profile can add missing information for infertile couples and clinicians, especially when they are considering IUI (Intrauterine Insemination), IVF (In Vitro Insemination), and/or ICSI (Intracytoplasmic Sperm Injection).Path Fertility's review of this capstone research, including the data gathered from preceding studies, confirms clinical data show that "up to 25% of men with a ‘normal' Semen Analysis result have sperm that are incapable of producing a healthy pregnancy without intervention via advanced fertility techniques."
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
Convenient Size at the Convenience Store
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug Development Strategy
US brothers guilty of luxury real estate sex-trafficking scheme: US media
Three brothers were found guilty of sex trafficking on Monday, following a trial that showed they used their high-profile connections in the luxury real estate world to assault women for years.
EU lawmakers back 'return hubs' for migrants
EU lawmakers on Monday gave preliminary backing to a tightening of Europe's immigration policy, paving the way for so-called "return hubs" for failed asylum-seekers, after centre-right and far-right deputies saw it through.
EU lawmakers set to greenlight 'return hubs' for migrants
A tightening of Europe's immigration policy paving the way for so-called "return hubs" for failed asylum-seekers is expected to gain the backing of EU lawmakers this week, with centre-right and far-right deputies joining hands to see it through.
Landmark trial opens for Turkish opposition champion Imamoglu
Istanbul's jailed mayor Ekrem Imamoglu went on trial on Monday in a sprawling corruption case critics say is a politically motivated bid to scupper his chances of challenging President Recep Tayyip Erdogan.
Indonesia landfill collapse kills five
A landslide on Indonesia's biggest landfill buried trucks and food stalls, killing five people, rescuers said Monday as they searched for at least four more reported missing.
Jail for up to 16 years for Australian hitmen who killed compatriot in Bali
Two Australian hitmen were sentenced to 16 years in prison Monday for shooting dead a compatriot over a debt dispute on the Indonesian resort island of Bali last year.
ZetrOZ Systems is a Premier Sponsor of Arthritis Foundation's Pathways Conference, Highlighting Drug Free Treatment Options for Knee Osteoarthritis
The developers of sustained acoustic medicine technology and the sam® wearable ultrasound device continue mission of advancing care for arthritis and soft tissue injuries at the Foundation's annual meeting and at the Global Knee Summit.
Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants
Strengthening balance sheet and capitalization is a key Jaguar priorityCompany continues its sharp, strategic focus on global development program for crofelemer for rare-disease intestinal failure indications
Beacon Oral Specialists Enters Jacksonville with North Florida Oral & Facial Surgery Partnership
Latest New Market Entry Caps Year of Strategic Expansion and Positions Company for Strong 2026
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)
GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs' primary side effectForzet targeting preservation of muscle while on GLP-1 agonist therapy to facilitate continued patient adherence and muscle redevelopment following therapy discontinuation to help mitigate weight regain
In Istanbul, despite ban, thousands march for Women's Day
Thousands of women marched through Istanbul to mark International Women's Day late Sunday defying a ban on demonstrations, with the rally passing without incident despite a heavy police presence, AFP correspondents said.
NY police say device thrown near anti-Islam protest was IED
A homemade incendiary thrown near anti-Islam protesters outside the New York mayor's residence was a viable improvised explosive device "that could have caused serious injury or death," police said Sunday.
Possible terror motive in US embassy blast, say Norway police
Oslo police said Sunday an explosion at the US embassy in Norway overnight may have been an act of terror, but stressed they were also investigating other possible causes.
Norway police says possible terror motive in US embassy blast
Oslo police said Sunday an explosion at the US embassy in Norway overnight that caused no injuries and minor material damage may have been an act of terror, but stressed police were also investigating other motives.